{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T14:49:04Z","timestamp":1785336544953,"version":"3.55.0"},"reference-count":95,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T00:00:00Z","timestamp":1767657600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T00:00:00Z","timestamp":1770076800000},"content-version":"vor","delay-in-days":28,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Med Res"],"DOI":"10.1186\/s40001-025-03613-0","type":"journal-article","created":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T15:48:58Z","timestamp":1767714538000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["G-CSF promotes H3K27ac-modified KLF5 to activate CXCR4 expression and drive colon cancer growth and metastasis"],"prefix":"10.1186","volume":"31","author":[{"given":"Guoqing","family":"Ma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tingting","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Canhui","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenhao","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wufeng","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianbao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,6]]},"reference":[{"issue":"1","key":"3613_CR1","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1186\/s13045-020-00991-2","volume":"13","author":"S Zhao","year":"2020","unstructured":"Zhao S, Mi Y, Guan B, Zheng B, Wei P, Gu Y, et al. Tumor-derived exosomal miR-934 induces macrophage M2 polarization to promote liver metastasis of colorectal cancer. J Hematol Oncol. 2020;13(1):156.","journal-title":"J Hematol Oncol"},{"issue":"15","key":"3613_CR2","doi-asserted-by":"publisher","first-page":"7507","DOI":"10.7150\/thno.59546","volume":"11","author":"J Chen","year":"2021","unstructured":"Chen J, Wu Y, Luo X, Jin D, Zhou W, Ju Z, et al. Circular RNA circRHOBTB3 represses metastasis by regulating the HuR-mediated mRNA stability of PTBP1 in colorectal cancer. Theranostics. 2021;11(15):7507\u201326.","journal-title":"Theranostics"},{"issue":"10","key":"3613_CR3","doi-asserted-by":"publisher","first-page":"1791","DOI":"10.1007\/s10529-012-0977-5","volume":"34","author":"S Jana","year":"2012","unstructured":"Jana S, Patel H. Expression of human granulocyte colony stimulating factor (hG-CSF) in colon adenocarcinoma cell line (Caco-2). Biotechnol Lett. 2012;34(10):1791\u20136.","journal-title":"Biotechnol Lett"},{"issue":"5","key":"3613_CR4","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1038\/bjc.2013.822","volume":"110","author":"KT Morris","year":"2014","unstructured":"Morris KT, Khan H, Ahmad A, Weston LL, Nofchissey RA, Pinchuk IV, et al. G-CSF and G-CSFR are highly expressed in human gastric and colon cancers and promote carcinoma cell proliferation and migration. Br J Cancer. 2014;110(5):1211\u201320.","journal-title":"Br J Cancer"},{"key":"3613_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/j.smim.2021.101516","volume":"54","author":"KR Martin","year":"2021","unstructured":"Martin KR, Wong HL, Witko-Sarsat V, Wicks IP. G-CSF - a double edge sword in neutrophil mediated immunity. Semin Immunol. 2021;54:101516.","journal-title":"Semin Immunol"},{"key":"3613_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/j.cyto.2021.155479","volume":"142","author":"I Karagiannidis","year":"2021","unstructured":"Karagiannidis I, Salataj E, Said Abu Egal E, Beswick EJ. G-CSF in tumors: aggressiveness, tumor microenvironment and immune cell regulation. Cytokine. 2021;142:155479.","journal-title":"Cytokine"},{"issue":"4","key":"3613_CR7","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1038\/bjc.1992.106","volume":"65","author":"A Suzuki","year":"1992","unstructured":"Suzuki A, Takahashi T, Okuno Y, Tsuyuoka R, Fukumoto M, Nakamura K, et al. IL-1 production as a regulator of G-CSF and IL-6 production in CSF-producing cell lines. Br J Cancer. 1992;65(4):515\u20138.","journal-title":"Br J Cancer"},{"issue":"9","key":"3613_CR8","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1007\/s11604-021-01130-8","volume":"39","author":"S Kohno","year":"2021","unstructured":"Kohno S, Furuta A, Arizono S, Tokunaga K, Nakao S, Tanabe M, et al. Imaging findings of granulocyte colony-stimulating factor-producing tumors: a case series and review of the literature. Jpn J Radiol. 2021;39(9):857\u201367.","journal-title":"Jpn J Radiol"},{"issue":"10","key":"3613_CR9","doi-asserted-by":"publisher","first-page":"968","DOI":"10.2174\/092986708784049649","volume":"15","author":"R Klocke","year":"2008","unstructured":"Klocke R, Kuhlmann MT, Scobioala S, Schabitz WR, Nikol S. Granulocyte colony-stimulating factor (G-CSF) for cardio- and cerebrovascular regenerative applications. Curr Med Chem. 2008;15(10):968\u201377.","journal-title":"Curr Med Chem"},{"issue":"19","key":"3613_CR10","doi-asserted-by":"publisher","first-page":"2783","DOI":"10.2169\/internalmedicine.2762-19","volume":"58","author":"S Kazama","year":"2019","unstructured":"Kazama S, Gokita T, Takano M, Ishikawa A, Nishimura Y, Ishii H, et al. G-CSF-producing undifferentiated pleomorphic sarcoma adjacent to the ascending colon and in the right iliopsoas muscle: a case report and review of the literature. Intern Med. 2019;58(19):2783\u20139.","journal-title":"Intern Med"},{"issue":"8","key":"3613_CR11","doi-asserted-by":"publisher","first-page":"3694","DOI":"10.62347\/IHIO5742","volume":"14","author":"YC Kuo","year":"2024","unstructured":"Kuo YC, Huang CY, Ng CCY, Lin CY, Huang WK, Lee LY, et al. Paraneoplastic leukocytosis induces NETosis and thrombosis in bladder cancer PDX model. Am J Cancer Res. 2024;14(8):3694\u2013710.","journal-title":"Am J Cancer Res"},{"issue":"11","key":"3613_CR12","doi-asserted-by":"publisher","first-page":"2158","DOI":"10.1158\/1078-0432.CCR-22-3918","volume":"29","author":"AL Ray","year":"2023","unstructured":"Ray AL, Saunders AS, Nofchissey RA, Reidy MA, Kamal M, Lerner MR, et al. G-CSF is a novel mediator of T-cell suppression and an immunotherapeutic target for women with colon cancer. Clin Cancer Res. 2023;29(11):2158\u201369.","journal-title":"Clin Cancer Res"},{"issue":"9","key":"3613_CR13","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1093\/jmcb\/mjaa016","volume":"12","author":"L Liu","year":"2020","unstructured":"Liu L, Wu Y, Zhang C, Zhou C, Li Y, Zeng Y, et al. Cancer-associated adipocyte-derived G-CSF promotes breast cancer malignancy via Stat3 signaling. J Mol Cell Biol. 2020;12(9):723\u201337.","journal-title":"J Mol Cell Biol"},{"issue":"25","key":"3613_CR14","doi-asserted-by":"publisher","first-page":"4932","DOI":"10.1038\/s41388-019-0763-0","volume":"38","author":"T Wang","year":"2019","unstructured":"Wang T, Song P, Zhong T, Wang X, Xiang X, Liu Q, et al. The inflammatory cytokine IL-6 induces FRA1 deacetylation promoting colorectal cancer stem-like properties. Oncogene. 2019;38(25):4932\u201347.","journal-title":"Oncogene"},{"issue":"2","key":"3613_CR15","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.gde.2006.02.015","volume":"16","author":"KP Nightingale","year":"2006","unstructured":"Nightingale KP, O\u2019Neill LP, Turner BM. Histone modifications: signalling receptors and potential elements of a heritable epigenetic code. Curr Opin Genet Dev. 2006;16(2):125\u201336.","journal-title":"Curr Opin Genet Dev"},{"issue":"11","key":"3613_CR16","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1038\/nrm1761","volume":"6","author":"C Martin","year":"2005","unstructured":"Martin C, Zhang Y. The diverse functions of histone lysine methylation. Nat Rev Mol Cell Biol. 2005;6(11):838\u201349.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"2","key":"3613_CR17","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.gde.2005.01.005","volume":"15","author":"R Margueron","year":"2005","unstructured":"Margueron R, Trojer P, Reinberg D. The key to development: interpreting the histone code? Curr Opin Genet Dev. 2005;15(2):163\u201376.","journal-title":"Curr Opin Genet Dev"},{"issue":"3","key":"3613_CR18","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1006\/bbrc.2001.4840","volume":"283","author":"Y Miyata","year":"2001","unstructured":"Miyata Y, Towatari M, Maeda T, Ozawa Y, Saito H. Histone acetylation induced by granulocyte colony-stimulating factor in a map kinase-dependent manner. Biochem Biophys Res Commun. 2001;283(3):655\u201360.","journal-title":"Biochem Biophys Res Commun"},{"key":"3613_CR19","doi-asserted-by":"publisher","DOI":"10.1093\/jmcb\/mjad045","author":"C Dou","year":"2024","unstructured":"Dou C, Wu L, Zhang J, He H, Xu T, Yu Z, et al. The transcriptional activator Klf5 recruits p300-mediated H3K27ac for maintaining trophoblast stem cell pluripotency. J Mol Cell Biol. 2024. https:\/\/doi.org\/10.1093\/jmcb\/mjad045.","journal-title":"J Mol Cell Biol"},{"issue":"6","key":"3613_CR20","doi-asserted-by":"publisher","first-page":"2097","DOI":"10.1111\/cas.14910","volume":"112","author":"Y Luo","year":"2021","unstructured":"Luo Y, Chen C. The roles and regulation of the KLF5 transcription factor in cancers. Cancer Sci. 2021;112(6):2097\u2013117.","journal-title":"Cancer Sci"},{"issue":"6","key":"3613_CR21","doi-asserted-by":"publisher","first-page":"2078","DOI":"10.1111\/cas.14411","volume":"111","author":"Y Takagi","year":"2020","unstructured":"Takagi Y, Sakai N, Yoshitomi H, Furukawa K, Takayashiki T, Kuboki S, et al. High expression of Kruppel-like factor 5 is associated with poor prognosis in patients with colorectal cancer. Cancer Sci. 2020;111(6):2078\u201392.","journal-title":"Cancer Sci"},{"issue":"1","key":"3613_CR22","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1158\/1535-7163.MCT-15-0600","volume":"15","author":"A Ruiz de Sabando","year":"2016","unstructured":"Ruiz de Sabando A, Wang C, He Y, Garcia-Barros M, Kim J, Shroyer KR, et al. ML264, a novel small-molecule compound that potently inhibits growth of colorectal cancer. Mol Cancer Ther. 2016;15(1):72\u201383.","journal-title":"Mol Cancer Ther"},{"key":"3613_CR23","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1186\/s12935-020-01527-x","volume":"20","author":"Q Liao","year":"2020","unstructured":"Liao Q, Chen L, Zhang N, Xi Y, Hu S, Ng DM, et al. Network analysis of KLF5 targets showing the potential oncogenic role of SNHG12 in colorectal cancer. Cancer Cell Int. 2020;20:439.","journal-title":"Cancer Cell Int"},{"issue":"1","key":"3613_CR24","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/s11658-025-00702-0","volume":"30","author":"Y Xie","year":"2025","unstructured":"Xie Y, Ni X, Wan X, Xu N, Chen L, Lin C, et al. KLF5 enhances CXCL12 transcription in adipose-derived stem cells to promote endothelial progenitor cells neovascularization and accelerate diabetic wound healing. Cell Mol Biol Lett. 2025;30(1):24.","journal-title":"Cell Mol Biol Lett"},{"issue":"31","key":"3613_CR25","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202304638","volume":"10","author":"Y Wu","year":"2023","unstructured":"Wu Y, Chen S, Shao Y, Su Y, Li Q, Wu J, et al. KLF5 promotes tumor progression and Parp inhibitor resistance in ovarian cancer. Adv Sci. 2023;10(31):e2304638.","journal-title":"Adv Sci"},{"key":"3613_CR26","first-page":"4953","volume":"9","author":"C Xu","year":"2015","unstructured":"Xu C, Zhao H, Chen H, Yao Q. CXCR4 in breast cancer: oncogenic role and therapeutic targeting. Drug Des Devel Ther. 2015;9:4953\u201364.","journal-title":"Drug Des Devel Ther"},{"issue":"4","key":"3613_CR27","doi-asserted-by":"publisher","first-page":"3307","DOI":"10.1007\/s11033-021-07069-3","volume":"49","author":"F Sadri","year":"2022","unstructured":"Sadri F, Rezaei Z, Fereidouni M. The significance of the SDF-1\/CXCR4 signaling pathway in the normal development. Mol Biol Rep. 2022;49(4):3307\u201320.","journal-title":"Mol Biol Rep"},{"issue":"3","key":"3613_CR28","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1007\/s10147-014-0740-0","volume":"20","author":"S Ma","year":"2015","unstructured":"Ma S, Li Q, Pan F. CXCR4 promotes GSK3beta expression in pancreatic cancer cells via the Akt pathway. Int J Clin Oncol. 2015;20(3):525\u201330.","journal-title":"Int J Clin Oncol"},{"issue":"1","key":"3613_CR29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12943-022-01695-6","volume":"22","author":"P Khan","year":"2023","unstructured":"Khan P, Siddiqui JA, Kshirsagar PG, Venkata RC, Maurya SK, Mirzapoiazova T, et al. MicroRNA-1 attenuates the growth and metastasis of small cell lung cancer through CXCR4\/FOXM1\/RRM2 axis. Mol Cancer. 2023;22(1):1.","journal-title":"Mol Cancer"},{"key":"3613_CR30","doi-asserted-by":"publisher","DOI":"10.3390\/cells13161334","author":"CY Chen","year":"2024","unstructured":"Chen CY, Yang SH, Chang PY, Chen SF, Nieh S, Huang WY, et al. Cancer-associated-fibroblast-mediated paracrine and autocrine SDF-1\/CXCR4 signaling promotes stemness and aggressiveness of colorectal cancers. Cells. 2024. https:\/\/doi.org\/10.3390\/cells13161334.","journal-title":"Cells"},{"issue":"4","key":"3613_CR31","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1586\/era.11.11","volume":"11","author":"JA Burger","year":"2011","unstructured":"Burger JA, Stewart DJ, Wald O, Peled A. Potential of CXCR4 antagonists for the treatment of metastatic lung cancer. Expert Rev Anticancer Ther. 2011;11(4):621\u201330.","journal-title":"Expert Rev Anticancer Ther"},{"key":"3613_CR32","doi-asserted-by":"publisher","DOI":"10.3892\/ijo.2022.5365","author":"Q Zhao","year":"2022","unstructured":"Zhao Q, Long Y, Cheng W, Huang Y, Li J, Li Y, et al. Visfatin inhibits colon cancer cell apoptosis and decreases chemosensitivity to 5\u2011FU by promoting the SDF\u20111\/CXCR4\/Akt axis. Int J Oncol. 2022. https:\/\/doi.org\/10.3892\/ijo.2022.5365.","journal-title":"Int J Oncol"},{"key":"3613_CR33","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1186\/1741-7015-10-85","volume":"10","author":"SS Zhang","year":"2012","unstructured":"Zhang SS, Han ZP, Jing YY, Tao SF, Li TJ, Wang H, et al. CD133(+)CXCR4(+) colon cancer cells exhibit metastatic potential and predict poor prognosis of patients. BMC Med. 2012;10:85.","journal-title":"BMC Med"},{"issue":"6","key":"3613_CR34","doi-asserted-by":"publisher","first-page":"2612","DOI":"10.7150\/thno.52199","volume":"11","author":"W Feng","year":"2021","unstructured":"Feng W, Huang W, Chen J, Qiao C, Liu D, Ji X, et al. CXCL12-mediated HOXB5 overexpression facilitates Colorectal Cancer metastasis through transactivating CXCR4 and ITGB3. Theranostics. 2021;11(6):2612\u201333.","journal-title":"Theranostics"},{"issue":"2","key":"3613_CR35","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1002\/cam4.20","volume":"2","author":"CM Gutschalk","year":"2013","unstructured":"Gutschalk CM, Yanamandra AK, Linde N, Meides A, Depner S, Mueller MM. GM-CSF enhances tumor invasion by elevated MMP-2, -9, and -26 expression. Cancer Med. 2013;2(2):117\u201329.","journal-title":"Cancer Med"},{"issue":"3","key":"3613_CR36","first-page":"629","volume":"55","author":"Y Han","year":"2019","unstructured":"Han Y, Liu C, Zhang D, Men H, Huo L, Geng Q, et al. Mechanosensitive ion channel Piezo1 promotes prostate cancer development through the activation of the Akt\/mTOR pathway and acceleration of cell cycle. Int J Oncol. 2019;55(3):629\u201344.","journal-title":"Int J Oncol"},{"issue":"11","key":"3613_CR37","doi-asserted-by":"publisher","first-page":"4935","DOI":"10.7150\/thno.73223","volume":"12","author":"Q Chen","year":"2022","unstructured":"Chen Q, Yang B, Liu X, Zhang XD, Zhang L, Liu T. Histone acetyltransferases CBP\/p300 in tumorigenesis and CBP\/p300 inhibitors as promising novel anticancer agents. Theranostics. 2022;12(11):4935\u201348.","journal-title":"Theranostics"},{"issue":"3","key":"3613_CR38","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1016\/j.critrevonc.2013.08.005","volume":"88","author":"L Lombardi","year":"2013","unstructured":"Lombardi L, Tavano F, Morelli F, Latiano TP, Di Sebastiano P, Maiello E. Chemokine receptor CXCR4: role in gastrointestinal cancer. Crit Rev Oncol Hematol. 2013;88(3):696\u2013705.","journal-title":"Crit Rev Oncol Hematol"},{"issue":"5","key":"3613_CR39","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1093\/annonc\/mdq222","volume":"21","author":"E Van Cutsem","year":"2010","unstructured":"Van Cutsem E, Nordlinger B, Cervantes A. Advanced colorectal cancer: ESMO clinical practice guidelines for treatment. Ann Oncol. 2010;21(5):93\u20137.","journal-title":"Ann Oncol"},{"issue":"1","key":"3613_CR40","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.cmet.2018.04.022","volume":"28","author":"W Li","year":"2018","unstructured":"Li W, Tanikawa T, Kryczek I, Xia H, Li G, Wu K, et al. Aerobic glycolysis controls myeloid-derived suppressor cells and tumor immunity via a specific CEBPB isoform in triple-negative breast cancer. Cell Metab. 2018;28(1):87\u2013103.","journal-title":"Cell Metab"},{"key":"3613_CR41","doi-asserted-by":"publisher","first-page":"18217","DOI":"10.1038\/srep18217","volume":"5","author":"M Kawano","year":"2015","unstructured":"Kawano M, Mabuchi S, Matsumoto Y, Sasano T, Takahashi R, Kuroda H, et al. The significance of G-CSF expression and myeloid-derived suppressor cells in the chemoresistance of uterine cervical cancer. Sci Rep. 2015;5:18217.","journal-title":"Sci Rep"},{"issue":"1","key":"3613_CR42","doi-asserted-by":"publisher","first-page":"419","DOI":"10.3892\/or.2013.2463","volume":"30","author":"CH Lee","year":"2013","unstructured":"Lee CH, Lin SH, Chang SF, Chang PY, Yang ZP, Lu SC. Extracellular signal-regulated kinase 2 mediates the expression of granulocyte colony-stimulating factor in invasive cancer cells. Oncol Rep. 2013;30(1):419\u201324.","journal-title":"Oncol Rep"},{"issue":"2","key":"3613_CR43","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1007\/s10549-019-05135-w","volume":"175","author":"L Guo","year":"2019","unstructured":"Guo L, Chen G, Zhang W, Zhou L, Xiao T, Di X, et al. A high-risk luminal A dominant breast cancer subtype with increased mobility. Breast Cancer Res Treat. 2019;175(2):459\u201372.","journal-title":"Breast Cancer Res Treat"},{"issue":"16","key":"3613_CR44","doi-asserted-by":"publisher","first-page":"8026","DOI":"10.1158\/0008-5472.CAN-06-0158","volume":"66","author":"CM Gutschalk","year":"2006","unstructured":"Gutschalk CM, Herold-Mende CC, Fusenig NE, Mueller MM. Granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor promote malignant growth of cells from head and neck squamous cell carcinomas in vivo. Cancer Res. 2006;66(16):8026\u201336.","journal-title":"Cancer Res"},{"key":"3613_CR45","doi-asserted-by":"publisher","DOI":"10.1186\/s40169-015-0048-3","volume":"4","author":"S Heerboth","year":"2015","unstructured":"Heerboth S, Housman G, Leary M, Longacre M, Byler S, Lapinska K, et al. EMT and tumor metastasis. Clin Transl Med. 2015;4:6.","journal-title":"Clin Transl Med"},{"issue":"4","key":"3613_CR46","doi-asserted-by":"publisher","first-page":"2136","DOI":"10.1111\/jcmm.16191","volume":"25","author":"J Ding","year":"2021","unstructured":"Ding J, Yang C, Zhang Y, Wang J, Zhang S, Guo D, et al. M2 macrophage-derived G-CSF promotes trophoblasts EMT, invasion and migration via activating PI3K\/Akt\/Erk1\/2 pathway to mediate normal pregnancy. J Cell Mol Med. 2021;25(4):2136\u201347.","journal-title":"J Cell Mol Med"},{"issue":"16","key":"3613_CR47","doi-asserted-by":"publisher","first-page":"2040","DOI":"10.1038\/onc.2015.263","volume":"35","author":"L Jia","year":"2016","unstructured":"Jia L, Zhou Z, Liang H, Wu J, Shi P, Li F, et al. KLF5 promotes breast cancer proliferation, migration and invasion in part by upregulating the transcription of TNFAIP2. Oncogene. 2016;35(16):2040\u201351.","journal-title":"Oncogene"},{"issue":"7","key":"3613_CR48","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1038\/s41416-020-0758-1","volume":"122","author":"Y Morimoto","year":"2020","unstructured":"Morimoto Y, Mizushima T, Wu X, Okuzaki D, Yokoyama Y, Inoue A, et al. miR-4711-5p regulates cancer stemness and cell cycle progression via KLF5, MDM2 and TFDP1 in colon cancer cells. Br J Cancer. 2020;122(7):1037\u201349.","journal-title":"Br J Cancer"},{"key":"3613_CR49","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2020.598880","volume":"11","author":"AK Siraj","year":"2020","unstructured":"Siraj AK, Pratheeshkumar P, Divya SP, Parvathareddy SK, Alobaisi KA, Thangavel S, et al. Krupple-like factor 5 is a potential therapeutic target and prognostic marker in epithelial ovarian cancer. Front Pharmacol. 2020;11:598880.","journal-title":"Front Pharmacol"},{"issue":"1","key":"3613_CR50","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1007\/s10565-024-09984-0","volume":"41","author":"X Wu","year":"2025","unstructured":"Wu X, Zhang X, Tang S, Wang Y. The important role of the histone acetyltransferases p300\/CBP in cancer and the promising anticancer effects of p300\/CBP inhibitors. Cell Biol Toxicol. 2025;41(1):32.","journal-title":"Cell Biol Toxicol"},{"key":"3613_CR51","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2024.116130","volume":"171","author":"P Gou","year":"2024","unstructured":"Gou P, Zhang W. Protein lysine acetyltransferase CBP\/p300: a promising target for small molecules in cancer treatment. Biomed Pharmacother. 2024;171:116130.","journal-title":"Biomed Pharmacother"},{"issue":"8","key":"3613_CR52","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1093\/neuonc\/noac051","volume":"24","author":"AC Mladek","year":"2022","unstructured":"Mladek AC, Yan H, Tian S, Decker PA, Burgenske DM, Bakken K, et al. RBBP4-p300 axis modulates expression of genes essential for cell survival and is a potential target for therapy in glioblastoma. Neuro Oncol. 2022;24(8):1261\u201372.","journal-title":"Neuro Oncol"},{"key":"3613_CR53","doi-asserted-by":"publisher","DOI":"10.3390\/antiox10091356","author":"AG Lazar","year":"2021","unstructured":"Lazar AG, Vlad ML, Manea A, Simionescu M, Manea SA. Activated histone acetyltransferase p300\/CBP-related signalling pathways mediate up-regulation of NADPH oxidase, inflammation, and fibrosis in diabetic kidney. Antioxidants. 2021. https:\/\/doi.org\/10.3390\/antiox10091356.","journal-title":"Antioxidants"},{"issue":"10","key":"3613_CR54","doi-asserted-by":"publisher","first-page":"2183","DOI":"10.1016\/j.molcel.2021.04.015","volume":"81","author":"SJ Hogg","year":"2021","unstructured":"Hogg SJ, Motorna O, Cluse LA, Johanson TM, Coughlan HD, Raviram R, et al. Targeting histone acetylation dynamics and oncogenic transcription by catalytic P300\/CBP inhibition. Mol Cell. 2021;81(10):2183\u2013200.","journal-title":"Mol Cell"},{"issue":"1","key":"3613_CR55","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.canlet.2011.06.028","volume":"312","author":"M Ma","year":"2011","unstructured":"Ma M, Ye JY, Deng R, Dee CM, Chan GC. Mesenchymal stromal cells may enhance metastasis of neuroblastoma via SDF-1\/CXCR4 and SDF-1\/CXCR7 signaling. Cancer Lett. 2011;312(1):1\u201310.","journal-title":"Cancer Lett"},{"issue":"2","key":"3613_CR56","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.canlet.2012.02.035","volume":"322","author":"X Li","year":"2012","unstructured":"Li X, Ma Q, Xu Q, Liu H, Lei J, Duan W, et al. SDF-1\/CXCR4 signaling induces pancreatic cancer cell invasion and epithelial-mesenchymal transition in vitro through non-canonical activation of Hedgehog pathway. Cancer Lett. 2012;322(2):169\u201376.","journal-title":"Cancer Lett"},{"issue":"1","key":"3613_CR57","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/s13046-018-1014-x","volume":"38","author":"X Yu","year":"2019","unstructured":"Yu X, Wang D, Wang X, Sun S, Zhang Y, Wang S, et al. CXCL12\/CXCR4 promotes inflammation-driven colorectal cancer progression through activation of RhoA signaling by sponging miR-133a-3p. J Exp Clin Cancer Res. 2019;38(1):32.","journal-title":"J Exp Clin Cancer Res"},{"issue":"1","key":"3613_CR58","doi-asserted-by":"publisher","first-page":"1714","DOI":"10.1038\/s41467-021-21976-w","volume":"12","author":"B Zhang","year":"2021","unstructured":"Zhang B, Li Y, Wu Q, Xie L, Barwick B, Fu C, et al. Acetylation of KLF5 maintains EMT and tumorigenicity to cause chemoresistant bone metastasis in prostate cancer. Nat Commun. 2021;12(1):1714.","journal-title":"Nat Commun"},{"issue":"1","key":"3613_CR59","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1186\/s12943-022-01653-2","volume":"21","author":"P Liu","year":"2022","unstructured":"Liu P, Wang Z, Ou X, Wu P, Zhang Y, Wu S, et al. The FUS\/circEZH2\/KLF5\/ feedback loop contributes to CXCR4-induced liver metastasis of breast cancer by enhancing epithelial-mesenchymal transition. Mol Cancer. 2022;21(1):198.","journal-title":"Mol Cancer"},{"issue":"9","key":"3613_CR60","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.1210\/me.2009-0010","volume":"23","author":"DE Frigo","year":"2009","unstructured":"Frigo DE, Sherk AB, Wittmann BM, Norris JD, Wang Q, Joseph JD, et al. Induction of Kruppel-like factor 5 expression by androgens results in increased CXCR4-dependent migration of prostate cancer cells in vitro. Mol Endocrinol. 2009;23(9):1385\u201396.","journal-title":"Mol Endocrinol"},{"issue":"9","key":"3613_CR61","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1038\/s41419-021-04109-5","volume":"12","author":"P Liu","year":"2021","unstructured":"Liu P, Sun H, Zhou X, Wang Q, Gao F, Fu Y, et al. CXCL12\/CXCR4 axis as a key mediator in atrial fibrillation via bioinformatics analysis and functional identification. Cell Death Dis. 2021;12(9):813.","journal-title":"Cell Death Dis"},{"issue":"2","key":"3613_CR62","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1038\/s41594-024-01397-1","volume":"32","author":"K Saotome","year":"2025","unstructured":"Saotome K, McGoldrick LL, Ho JH, Ramlall TF, Shah S, Moore MJ, et al. Structural insights into CXCR4 modulation and oligomerization. Nat Struct Mol Biol. 2025;32(2):315\u201325.","journal-title":"Nat Struct Mol Biol"},{"issue":"11","key":"3613_CR63","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2425795122","volume":"122","author":"X Sang","year":"2025","unstructured":"Sang X, Jiao H, Meng Q, Fang X, Pan Q, Zhou J, et al. Structural mechanisms underlying the modulation of CXCR4 by diverse small-molecule antagonists. Proc Natl Acad Sci U S A. 2025;122(11):e2425795122.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"16","key":"3613_CR64","doi-asserted-by":"publisher","first-page":"5522","DOI":"10.1158\/0008-5472.CAN-10-3143","volume":"71","author":"E Righi","year":"2011","unstructured":"Righi E, Kashiwagi S, Yuan J, Santosuosso M, Leblanc P, Ingraham R, et al. CXCL12\/CXCR4 blockade induces multimodal antitumor effects that prolong survival in an immunocompetent mouse model of ovarian cancer. Cancer Res. 2011;71(16):5522\u201334.","journal-title":"Cancer Res"},{"issue":"29","key":"3613_CR65","doi-asserted-by":"publisher","first-page":"27763","DOI":"10.18632\/oncotarget.4615","volume":"6","author":"VR Katkoori","year":"2015","unstructured":"Katkoori VR, Basson MD, Bond VC, Manne U, Bumpers HL. Nef-M1, a peptide antagonist of CXCR4, inhibits tumor angiogenesis and epithelial-to-mesenchymal transition in colon and breast cancers. Oncotarget. 2015;6(29):27763\u201377.","journal-title":"Oncotarget"},{"issue":"12","key":"3613_CR66","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0189156","volume":"12","author":"H Yang","year":"2017","unstructured":"Yang H, Chen Q, Sun F, Zhao N, Wen L, Li L, et al. Down-regulation of the klf5-c-Myc interaction due to klf5 phosphorylation mediates resveratrol repressing the caveolin-1 transcription through the PI3K\/PKD1\/Akt pathway. PLoS ONE. 2017;12(12):e0189156.","journal-title":"PLoS ONE"},{"issue":"1","key":"3613_CR67","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1186\/s13018-023-04437-6","volume":"18","author":"Y Jiang","year":"2023","unstructured":"Jiang Y, Gao Y, Li X, He F, Liu Y, Wang R. Caulis Spatholobi extracts inhibit osteosarcoma growth and metastasis through suppression of CXCR4\/PI3K\/AKT signaling. J Orthop Surg Res. 2023;18(1):985.","journal-title":"J Orthop Surg Res"},{"key":"3613_CR68","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1186\/s13578-019-0315-x","volume":"9","author":"X Tian","year":"2019","unstructured":"Tian X, Xie G, Xiao H, Ding F, Bao W, Zhang M. CXCR4 knockdown prevents inflammatory cytokine expression in macrophages by suppressing activation of MAPK and NF-kappaB signaling pathways. Cell Biosci. 2019;9:55.","journal-title":"Cell Biosci"},{"issue":"16","key":"3613_CR69","doi-asserted-by":"publisher","first-page":"2691","DOI":"10.1007\/s00018-009-0045-z","volume":"66","author":"JT Dong","year":"2009","unstructured":"Dong JT, Chen C. Essential role of KLF5 transcription factor in cell proliferation and differentiation and its implications for human diseases. Cell Mol Life Sci. 2009;66(16):2691\u2013706.","journal-title":"Cell Mol Life Sci"},{"key":"3613_CR70","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.93968","author":"EM Garcia-Cuesta","year":"2024","unstructured":"Garcia-Cuesta EM, Martinez P, Selvaraju K, Ulltjarn G, Gomez Pozo AM, D\u2019Agostino G, et al. Allosteric modulation of the CXCR4:CXCL12 axis by targeting receptor nanoclustering via the TMV-TMVI domain. Elife. 2024. https:\/\/doi.org\/10.7554\/eLife.93968.","journal-title":"Elife"},{"key":"3613_CR71","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1016\/j.actbio.2024.02.007","volume":"177","author":"R Wei","year":"2024","unstructured":"Wei R, Li J, Lin W, Pang X, Yang H, Lai S, et al. Nanoparticle-mediated blockade of CXCL12\/CXCR4 signaling enhances glioblastoma immunotherapy: monitoring early responses with MRI radiomics. Acta Biomater. 2024;177:414\u201330.","journal-title":"Acta Biomater"},{"issue":"2","key":"3613_CR72","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1053\/j.gastro.2024.02.025","volume":"167","author":"J Chen","year":"2024","unstructured":"Chen J, Feng W, Sun M, Huang W, Wang G, Chen X, et al. TGF-beta1-induced SOX18 elevation promotes hepatocellular carcinoma progression and metastasis through transcriptionally upregulating PD-L1 and CXCL12. Gastroenterology. 2024;167(2):264\u201380.","journal-title":"Gastroenterology"},{"issue":"6","key":"3613_CR73","doi-asserted-by":"publisher","first-page":"8729","DOI":"10.1021\/acsnano.1c07492","volume":"16","author":"MS Alghamri","year":"2022","unstructured":"Alghamri MS, Banerjee K, Mujeeb AA, Mauser A, Taher A, Thalla R, et al. Systemic delivery of an adjuvant CXCR4-CXCL12 signaling inhibitor encapsulated in synthetic protein nanoparticles for glioma immunotherapy. ACS Nano. 2022;16(6):8729\u201350.","journal-title":"ACS Nano"},{"issue":"5","key":"3613_CR74","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1038\/s41419-021-03730-8","volume":"12","author":"MA Nengroo","year":"2021","unstructured":"Nengroo MA, Maheshwari S, Singh A, Verma A, Arya RK, Chaturvedi P, et al. CXCR4 intracellular protein promotes drug resistance and tumorigenic potential by inversely regulating the expression of Death Receptor 5. Cell Death Dis. 2021;12(5):464.","journal-title":"Cell Death Dis"},{"issue":"1","key":"3613_CR75","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1186\/s13058-023-01665-w","volume":"25","author":"S Liu","year":"2023","unstructured":"Liu S, Xie SM, Liu W, Gagea M, Hanker AB, Nguyen N, et al. Targeting CXCR4 abrogates resistance to trastuzumab by blocking cell cycle progression and synergizes with docetaxel in breast cancer treatment. Breast Cancer Res. 2023;25(1):62.","journal-title":"Breast Cancer Res"},{"issue":"6","key":"3613_CR76","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1111\/j.1349-7006.2004.tb03242.x","volume":"95","author":"T Takahashi","year":"2004","unstructured":"Takahashi T, Morotomi M, Nomoto K. A novel mouse model of rectal cancer established by orthotopic implantation of colon cancer cells. Cancer Sci. 2004;95(6):514\u20139.","journal-title":"Cancer Sci"},{"issue":"1","key":"3613_CR77","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s12915-017-0472-5","volume":"16","author":"J Penarando","year":"2018","unstructured":"Penarando J, Lopez-Sanchez LM, Mena R, Guil-Luna S, Conde F, Hernandez V, et al. A role for endothelial nitric oxide synthase in intestinal stem cell proliferation and mesenchymal colorectal cancer. BMC Biol. 2018;16(1):3.","journal-title":"BMC Biol"},{"issue":"2","key":"3613_CR78","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1038\/s41419-020-2338-y","volume":"11","author":"S Mo","year":"2020","unstructured":"Mo S, Zhang L, Dai W, Han L, Wang R, Xiang W, et al. Antisense lncRNA LDLRAD4-AS1 promotes metastasis by decreasing the expression of LDLRAD4 and predicts a poor prognosis in colorectal cancer. Cell Death Dis. 2020;11(2):155.","journal-title":"Cell Death Dis"},{"issue":"1","key":"3613_CR79","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1186\/s12974-022-02566-z","volume":"19","author":"M Balogh","year":"2022","unstructured":"Balogh M, Zhang J, Gaffney CM, Kalakuntla N, Nguyen NT, Trinh RT, et al. Sensory neuron dysfunction in orthotopic mouse models of colon cancer. J Neuroinflammation. 2022;19(1):204.","journal-title":"J Neuroinflammation"},{"issue":"6","key":"3613_CR80","first-page":"3145","volume":"11","author":"CH Song","year":"2021","unstructured":"Song CH, Kim N, Nam RH, Choi SI, Yu JE, Nho H, et al. Testosterone strongly enhances azoxymethane\/dextran sulfate sodium-induced colorectal cancer development in C57BL\/6 mice. Am J Cancer Res. 2021;11(6):3145\u201362.","journal-title":"Am J Cancer Res"},{"issue":"2","key":"3613_CR81","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1097\/01.qai.0000137371.80695.ef","volume":"37","author":"CW Hendrix","year":"2004","unstructured":"Hendrix CW, Collier AC, Lederman MM, Schols D, Pollard RB, Brown S, et al. Safety, pharmacokinetics, and antiviral activity of AMD3100, a selective CXCR4 receptor inhibitor, in HIV-1 infection. J Acquir Immune Defic Syndr. 2004;37(2):1253\u201362.","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"11","key":"3613_CR82","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.1114","volume":"12","author":"T Ugai","year":"2022","unstructured":"Ugai T, Liu L, Tabung FK, Hamada T, Langworthy BW, Akimoto N, et al. Prognostic role of inflammatory diets in colorectal cancer overall and in strata of tumor-infiltrating lymphocyte levels. Clin Transl Med. 2022;12(11):e1114.","journal-title":"Clin Transl Med"},{"key":"3613_CR83","doi-asserted-by":"publisher","first-page":"1407449","DOI":"10.3389\/fimmu.2024.1407449","volume":"15","author":"W Liu","year":"2024","unstructured":"Liu W, Kuang T, Liu L, Deng W. The role of innate immune cells in the colorectal cancer tumor microenvironment and advances in anti-tumor therapy research. Front Immunol. 2024;15:1407449.","journal-title":"Front Immunol"},{"key":"3613_CR84","doi-asserted-by":"publisher","first-page":"1295863","DOI":"10.3389\/fimmu.2024.1295863","volume":"15","author":"C Eich","year":"2024","unstructured":"Eich C, Vogt JF, Langst V, Clausen BE, Hovelmeyer N. Isolation and high-dimensional flow cytometric analysis of tumor-infiltrating leukocytes in a mouse model of colorectal cancer. Front Immunol. 2024;15:1295863.","journal-title":"Front Immunol"},{"issue":"3","key":"3613_CR85","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1016\/j.clnu.2022.01.001","volume":"41","author":"X Chao","year":"2022","unstructured":"Chao X, Lei Z, Hongqin L, Ziwei W, Dechuan L, Weidong D, et al. Faeces from malnourished colorectal cancer patients accelerate cancer progression. Clin Nutr. 2022;41(3):632\u201344.","journal-title":"Clin Nutr"},{"issue":"14","key":"3613_CR86","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v31.i14.104588","volume":"31","author":"KJ Li","year":"2025","unstructured":"Li KJ, Zhang ZY, Wang K, Sulayman S, Zeng XY, Liu J, et al. Prognostic scoring system using inflammation- and nutrition-related biomarkers to predict prognosis in stage I-III colorectal cancer patients. World J Gastroenterol. 2025;31(14):104588.","journal-title":"World J Gastroenterol"},{"issue":"4","key":"3613_CR87","doi-asserted-by":"publisher","DOI":"10.3892\/ol.2025.14943","volume":"29","author":"K Li","year":"2025","unstructured":"Li K, Zeng X, Zhang Z, Wang K, Pan Y, Wu Z, et al. Pan\u2011immune\u2011inflammatory values predict survival in patients after radical surgery for non\u2011metastatic colorectal cancer: a retrospective study. Oncol Lett. 2025;29(4):197.","journal-title":"Oncol Lett"},{"issue":"1","key":"3613_CR88","doi-asserted-by":"publisher","first-page":"8902","DOI":"10.1038\/s41598-025-94126-7","volume":"15","author":"K Wang","year":"2025","unstructured":"Wang K, Li K, Zhang Z, Zeng X, Sulayman S, Ababaike S, et al. Prognostic value of combined NP and LHb index with absolute monocyte count in colorectal cancer patients. Sci Rep. 2025;15(1):8902.","journal-title":"Sci Rep"},{"issue":"5","key":"3613_CR89","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1017\/S0007114518002222","volume":"122","author":"MJ Wiseman","year":"2019","unstructured":"Wiseman MJ. Nutrition and cancer: prevention and survival. Br J Nutr. 2019;122(5):481\u20137.","journal-title":"Br J Nutr"},{"issue":"1","key":"3613_CR90","doi-asserted-by":"publisher","first-page":"17570","DOI":"10.1038\/s41598-023-43736-0","volume":"13","author":"Y Liu","year":"2023","unstructured":"Liu Y, Liu X, Duan L, Zhao Y, He Y, Li W, et al. Prognostic value of the combined effect of nutritional status and body water component in patients with colorectal cancer. Sci Rep. 2023;13(1):17570.","journal-title":"Sci Rep"},{"issue":"10","key":"3613_CR91","first-page":"4947","volume":"11","author":"M Tamai","year":"2021","unstructured":"Tamai M, Kiuchi J, Kuriu Y, Arita T, Shimizu H, Ohashi T, et al. Clinical impact of postoperative prognostic nutritional index in colorectal cancer patients undergoing adjuvant chemotherapy. Am J Cancer Res. 2021;11(10):4947\u201355.","journal-title":"Am J Cancer Res"},{"issue":"3","key":"3613_CR92","doi-asserted-by":"publisher","DOI":"10.4240\/wjgs.v17.i3.102638","volume":"17","author":"Y Shu","year":"2025","unstructured":"Shu Y, Li KJ, Sulayman S, Zhang ZY, Ababaike S, Wang K, et al. Predictive value of serum calcium ion level in patients with colorectal cancer: a retrospective cohort study. World J Gastrointest Surg. 2025;17(3):102638.","journal-title":"World J Gastrointest Surg"},{"issue":"1","key":"3613_CR93","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1111\/bjd.19795","volume":"185","author":"K Wolk","year":"2021","unstructured":"Wolk K, Brembach TC, Simaite D, Bartnik E, Cucinotta S, Pokrywka A, et al. Activity and components of the granulocyte colony-stimulating factor pathway in hidradenitis suppurativa. Br J Dermatol. 2021;185(1):164\u201376.","journal-title":"Br J Dermatol"},{"issue":"7","key":"3613_CR94","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1002\/art.42104","volume":"74","author":"B Malengier-Devlies","year":"2022","unstructured":"Malengier-Devlies B, Bernaerts E, Ahmadzadeh K, Filtjens J, Vandenhaute J, Boeckx B, et al. Role for granulocyte colony-stimulating factor in neutrophilic extramedullary myelopoiesis in a murine model of systemic juvenile idiopathic arthritis. Arthritis Rheumatol. 2022;74(7):1257\u201370.","journal-title":"Arthritis Rheumatol"},{"key":"3613_CR95","doi-asserted-by":"publisher","DOI":"10.3390\/antiox10101600","author":"N Shi","year":"2021","unstructured":"Shi N, Chen X, Chen T. Anthocyanins in colorectal cancer prevention review. Antioxidants. 2021. https:\/\/doi.org\/10.3390\/antiox10101600.","journal-title":"Antioxidants"}],"container-title":["European Journal of Medical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40001-025-03613-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40001-025-03613-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40001-025-03613-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T15:03:13Z","timestamp":1770130993000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s40001-025-03613-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,6]]},"references-count":95,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["3613"],"URL":"https:\/\/doi.org\/10.1186\/s40001-025-03613-0","relation":{},"ISSN":["2047-783X"],"issn-type":[{"value":"2047-783X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,6]]},"assertion":[{"value":"30 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All animal experiments were approved by the Ethics Committee of Laboratory Animal Center of Shenzhen University (Approval No. A202200108), and conducted in accordance with institutional and national guidelines for the care and use of laboratory animals. All procedures were designed to minimize animal suffering and distress.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"207"}}